AstraZeneca Pharma India Ltd. — Board/Management Information 2020

Aug 12, 2020

==> picture [571 x 82] intentionally omitted <==

August 12, 2020

The Manager ‐ Listing

National Stock Exchange of India Ltd.

Exchange plaza, 5[th] Floor, Plot No. C/1, G Block Bandra‐Kurla Complex, Bandra (E), Mumbai 400051

The Manager ‐ Listing

BSE Limited

Corporate Relationship Dept., 1[st] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai 400001

Dear Sir(s),

Sub: Appointment of Directors at Annual General Meeting held on August 10, 2020

We wish to inform you that at the Company’s Annual General Meeting held on August 10, 2020, the Shareholders have approved the following appointments:

1. Appointment of Mr. Ankush Nandra as Non‐Executive Director

2. Re‐appointment of Mr. Gagandeep Singh Bedi as the Managing Director for a term of 3 years w.e.f. July 1, 2020

3. Re‐appointment of Mr. Rajesh Marwaha as Whole‐time Director for a term of 3 years w.e.f. December 2, 2019

A brief profile of the directors appointed is enclosed herewith.

None of the above directors are related to any other director of the Company.

We request you to please take the same on record.

Thanking you,

Yours faithfully

For AstraZeneca Pharma India Limited

Digitally signed by PRATAP PRATAP RUDRA RUDRA BHUVANAGIRI BHUVANAGIRI Date: 2020.08.12 20:42:51 +05'30'

Pratap Rudra

Company Secretary & Legal Counsel

==> picture [452 x 64] intentionally omitted <==

Mr. Ankush Nandra

Mr. Ankush Nandra in his current role is based in the UK. He leads the commercial finance organisation across the International Region. He is a member of both the International Leadership Team as well as the Global Finance Leadership Team.

He joined AstraZeneca in 2015 as the European CFO before moving to his present role in 2018. Prior to joining AstraZeneca, he spent 16 years at GSK based in the UK, US and Australia for a variety of commercial and corporate roles.

Before GSK he spent time in M&A with HSBC Investment Bank following qualification as an ACA with KPMG.

Mr. Gagandeep Singh Bedi

Mr. Gagandeep Singh Bedi joined the Company in February 2006. He held various roles as a Business Director and later as Director Strategic Planning. He also held the position of Vice President‐Sales & Marketing – Cardiac and Diabetes.

In 2012, he was appointed as the Country President for AstraZeneca Philippines. Post a successful stint in this role, he moved to the United Kingdom as Global Head of Established Brands and Global Medical Lead – Gastrointestinal / Cardio Vascular.

Prior to joining AstraZeneca, he had worked with Baxter India and Eli Lilly.

Mr. Rajesh Marwaha

Mr. Rajesh Marwaha has been the Chief Financial Officer of the Company since August 2014.

He has over twenty‐ four years of Indian and International working experience. His experience includes varied roles in FMCG, Home Appliances, Pharmaceutical and Retail Mall sector. During his past work tenure, his main experience has been to set up new subsidiaries in different countries which has developed a strong business enabling approach in him.

He is a member of the Institute of Chartered Accountants of India.

Prior to joining AstraZeneca, he had worked with PepsiCo for seven years. He joined Groupe SEB SA, a French company in home appliances business in 1996. There, he worked in different functions; finance in India, Global internal audit at headquarter in France, Regional Controller Sales & Commercial in Dubai. Post a successful stint, he came back to India to join MSD pharmaceuticals in India in 2008 and worked there for 6 years.